Cardinal Health Inc. (CAH)

Cardinal Health Inc. (CAH $186.35)
- $186.35 P/E (TTM): 27.91X Cap: $43.64B
- View CAH Profile
- View Questions on CAH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Cardinal Health Inc. (CAH $186.35)
- $186.35 P/E (TTM): 27.91X Cap: $43.64B
- View CAH Profile
- View Questions on CAH
McKesson Corporation (MCK $737.18)
- $737.18 P/E (TTM): 19.14X Cap: $88.61B
- View MCK Profile
- View Questions on MCK
Cencora Inc. (COR $255.68)
- $255.68 P/E (TTM): 31.18X Cap: $49.74B
- View COR Profile
- View Questions on COR

Q: Any thoughts or recommendations on the recent results and yesterday's conference call

Read Answer Asked by Lakis on May 08, 2026

Cardinal Health Inc. (CAH $186.35)
- $186.35 P/E (TTM): 27.91X Cap: $43.64B
- View CAH Profile
- View Questions on CAH
McKesson Corporation (MCK $737.18)
- $737.18 P/E (TTM): 19.14X Cap: $88.61B
- View MCK Profile
- View Questions on MCK

Q: Hi - do you have a preference between these two drug distribution companies? If you would avoid both at this time, then that's fine too!

Read Answer Asked by Doug on March 08, 2024

Intuitive Surgical Inc. (ISRG $432.27)
- $432.27 P/E (TTM): 51.04X Cap: $153.09B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $208.50)
- $208.50 P/E (TTM): 85.92X Cap: $368.37B
- View ABBV Profile
- View Questions on ABBV
Cardinal Health Inc. (CAH $186.35)
- $186.35 P/E (TTM): 27.91X Cap: $43.64B
- View CAH Profile
- View Questions on CAH
Johnson & Johnson (JNJ $230.42)
- $230.42 P/E (TTM): 20.33X Cap: $554.66B
- View JNJ Profile
- View Questions on JNJ
Stryker Corporation (SYK $302.09)
- $302.09 P/E (TTM): 33.56X Cap: $115.80B
- View SYK Profile
- View Questions on SYK
Guardant Health Inc. (GH $98.47)
- $98.47 Cap: $13.05B
- View GH Profile
- View Questions on GH

Q: Hello 5i Team.

Thank you for all the insights into investing - it has been profitable both educationally and financially.

7% of our portfolio is in geared to health care with a holding of 5 stocks , GUD - (slightly underwater but is the hopeful flyer), Medtronic - MDT, Cardinal Health - CAH, Abbvie - ABBV, Johnson & Johnson- JNJ. In an effort to reduce the overall number of stocks in our TFSA, RRSP and taxable accounts I was considering liquidating CAH and JNJ and either purchasing more ABBV or adding SYK, unless of course you can recommend another US health care stock. JNJ and and CAH have been the laggards of the US group since my initial purchases. I realize MDT and SYK might be similar but i do believe surgeries should increase in 2022.

I enjoy reading your resources and recommend it often.

Kevin

Read Answer Asked by Kevin on June 30, 2021